NCDC Director-General, Dr Chikwe Ihekweazu, disclosed this at a Presidential Task Force briefing on COVID-19 on Thursday.
According to him, the decision to stop the use of antiviral drugs on Coronavirus patients was as a result of the latest research on case management.
“We have removed the use of antivirals from our treatment guidelines.
“One that was in our guidelines recently was the lopinavir/ritonavir combination, which is a combination of medicines we use for HIV.
“There have been quite a number of studies now that have shown that they don’t really improve the outcome of this illness, so we’ve withdrawn them from the guidelines of management.”
Last month, the Health Minister, Osagie Ehanire, revealed that the four drugs that will be monitored in the COVID-19 solidarity trial are Remdesivir; Chloroquine or hydroxychloroquine; Lopinavir, and Ritonavir.